Muhammad Aslam Channa, Muhammad Ashfaq, Abdul Lateef Jokhio, Muhammad Zaheer Khan, Mir Muhammad Sahito


Background: Administration of quinolone therapy is controversial during growing age as
stated by earlier authors. The flouroquinolones are currently not indicated for young
children because of arthropathy and adverse effect as new born shown by studies. However
the effects of ciprofloxacin and ZnCl2 on prenatal conceptus have remained undocumented.
The present study was designed to compare the effects on conceptus after maternal
ingestion of ciprofloxacin and ZnCl2 using Wastar albino rats. Methods: Ciprofloxacin and
ZnCl2 was administrated to pregnant female albino rats. Ciprofloxacin with a dose of 20
mg/Kg bodyweight and ZnCl2 120 µg/100 gm bodyweight two times therapeutic dose for
10 days (from day 8–18 of pregnancy). Each animal was weighted on day 1, day 8 and day
18 of pregnancy. Abortion resulted on day 18th of pregnancy. Each group of pregnant
animals were sacrificed on day 18 of gestation by over dose of either anaesthesia, abdomen
opened, uterus and both cornua containing conceptus identified, removed, there weight
recorded, crown rump length was measured and was compared with similar value of control
animals. The results were statistically analysed to find out the significance. Results: The
ciprofloxacin induces a mordanting effect as obviated by increased basophilia. Our study
reveals that ciprofloxacin administered in maternal, decreased maternal body weight to
38.4±0.9 gm. However simultaneous ZnCl2 maintained the body weight to 41.4±0.7 gm,
while ZnCl2 increased the body weight to 46.5±2.25 gm. The body weight and Crown
Rump length (CR Length) in conceptus decreased by 4.52±0.10 gm and 3.06±0.09 Cm
respectively. That ciprofloxacin and ZnCl2 administration maintained the body weight and
CR length by 5.46±0.09 gm and 3.79±0.13 Cm respectively. That ZnCl2 administration
increased the body weight and CR length by 6.71±0.05 gm and 4.15±0.08 Cm respectively.
Conclusion: Prenatal administration of Ciprofloxacin caused reduction in growth rate and
CR length, and ZnCl2 maintained body weight and CR length and growth of the rat
Keywords: Ciprofloxacin, ZnCl2, body weight, crown rump length, conceptus

Full Text:



Gangopadhyay Nibaren, Daniell Mark, Weigh LO Anna, Taylor

Heigh R. Fluoroquinlone and fortified antibiotics for treating

bacterial corneal ulcers. Br J Ophthalmol 2000;84(4):378–84.

Nelson JM, Chiller TM, Powers Jh, Angulo FJ. Fluoroquinoloneresistant compilobacter species and the withdrawal of

fluoroquinlones from use in poultry: a public health success story

Clin Infect Dis 2007;44(7);977–80.

Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C,

Gerding DN. Therapy of lower extremity infections with

ciprofloxacin in patient with diabetes mellitus, peripheral

vascular disease or both. Am J Med 1987;86:801–8.

Katzang BG. fluoroquinlones in: Basic & Clinical Pharmacology

th Ed. New york: Me Graw Hill 2007;p. 797–801.

Gillman GA, Hardman JG, Limbird LE. The quinolones. In:

Goodman & Gillman: The pharmacological basis of therapeutics.

th ed. New York. McGraw Hill 2007;11:1179–83.

Grassmick BK, Lehr VJ, Sundareson AS. Fulminant hepatic

failure possibly related to ciprofloxacin. Ann Pharmacother


Simpson J, Wasten AR, Mellersh A, Nelson CS, Dodd K.

Typhoid fever ciprofloxacin and renal failure. Arch Disc Child


Greenberg RN, Kennedy DJ, Reilly PM, Luppen KL. Treatment

of bones joint and soft tissue infections with oral ciprofloxacin

Anti Microb Agent Chemother 1987;31:151–5.

Hooper DC, Wolfsons Js, Swartz MN. Mechanism of action and

resistance to ciprofloxacin. Am J Med 1987;82(54):12–20.

Pfister K, Manzur D, Vormann J, Stahlmann R. Diminshed

ciprofloxacine-induced chondrotoxicity by suplimentation with

Magnecium and vitamin E in immature rats. Anti Microb Agent

and Chemother 2007;51(3)1022–7.

Arora NK. Are fluroquinolones safe in children? Indian J Pediatr:


Williams SB, Southern LL, Bidner TD. Effects of supplemental

dietary phytase and pharmacological concentrations of Zinc on

growth performance and tissue Zinc concentration of weanling

pigs. J Anim Sci 2005;83:386–92.

Rough R. Reproductive system in the mouse. 2nd ed,

Minneapolis; Burgess Pub Co. 1968; p. 269–99.

Lori EK, Slick KK. Experimental foetal alcohol syndrome

proposed pathogenic basis for a variety of associated facial and

brain anomalies. Am J Gen Med 1992;44:168–76.

Martindale W. The complete drug reference 33rd ed. Sweetman

SC London, Chicago Pharmaceutical Press 2002;182–5.

Bland M. Introductioin of medical statistics 1st ed. Oxford,

Oxford University Press 1987;p.165–87.

Drlica K, Zhao XK. DNA gyase, topoisomerase IV and 4-

quinolones. Microbiol Mol Biol Rev 1997;61(3):377–92.

Robinson MJ, Mortin BA, Gootz TD, McGuirk PR, Osheroff N.

Effects of Novel fluoroquinolones on the catalytic activities of

eukaryotic topoisomerase II: Influnce of the C-8 fluorine group.

Anti Microb Agent Chemother 1992;36(4):751–6.

Sissi C, Palumbo MC. The quinolone family: from antibacterial

to anticancer agents. Curr Med Chem Anticancer Agents


Dowd RO, Kent JC, Moseley JM, Wlodek ME. Effects of

uteroplacental insufficiency and reducing litter size on maternal

mammary function and post natal offspring growth. Am J Physiol


Mehlman CT, Methew E, Koeppling DO. Growth plate (physeal)

fractures: Treatment 2010. Available at:


WHO contributors. The impact of zinc supplemention on

childhood mortality and severe morbidity. World Health

Organization 2007. Available at: http:/www.who.int/childadolesecent-health/zinc-mortality.html.


  • There are currently no refbacks.

Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]